Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 21.2% during trading on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares changed hands during mid-day trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The firm has a market cap of C$25.10 million, a price-to-earnings ratio of -18.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The company’s fifty day moving average is C$0.11 and its 200 day moving average is C$0.08.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- What is Forex and How Does it Work?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Are Penny Stocks a Good Fit for Your Portfolio?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- How to Use the MarketBeat Dividend Calculator
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
